Table 1.
T1DM (n = 76) | T2DM (n = 575) | P | |
---|---|---|---|
Age, years | 60 ± 14 | 65 ± 13 | 0.001 |
Sex, men | 31 (40.8) | 312 (54.3) | 0.028 |
BMI | 23 ± 4 | 25 ± 4 | <0.001 |
Systolic BP, mmHg | 135 ± 16 | 139 ± 18 | 0.044 |
Diastolic BP, mmHg | 77 ± 11 | 78 ± 12 | 0.381 |
Heart rate, per min | 81 ± 13 | 81 ± 14 | 0.956 |
Current smoking habit | 10 (13.5) | 111 (17.5) | 0.510 |
Alcohol drinking habit | 17 (23.0) | 160 (25.6) | 0.672 |
Duration of DM, years | 12 (5–26) | 14 (6–22) | 0.939 |
Family history | |||
DM | 36 (47.4) | 339 (59.0) | 0.064 |
Comorbidity | |||
Hypertension | 47 (61.8) | 422 (73.4) | 0.041 |
Cardiovascular disease | 15 (19.7) | 209 (36.4) | 0.014 |
Medication | |||
Anti-diabetic drugs | |||
Insulin | 76 (100) | 212 (36.9) | <0.001 |
GLP-1 analogs | 1 (1.3) | 31 (5.4) | 0.160 |
Sulfonylureas | 0 (0) | 166 (28.9) | <0.001 |
Biguanides | 11 (14.5) | 309 (53.7) | <0.001 |
α-glucosidase inhibitors | 5 (6.6) | 95 (16.5) | 0.026 |
DPP-4 inhibitors | 18 (23.7) | 414 (72.0) | <0.001 |
Glinides | 0 (0) | 49 (8.5) | 0.004 |
SGLT2 inhibitors | 0 (0) | 10 (1.7) | 0.616 |
Anti-dyslipidemic drugs | |||
Statin | 29 (38.2) | 302 (52.5) | 0.020 |
Biochemical data | |||
Total protein, g/dL | 7.2 ± 0.4 | 7.3 ± 0.5 | 0.018 |
AST, IU/L | 21 (17–25) | 21 (17–28) | 0.378 |
ALT, IU/L | 18 (13–23) | 19 (14–28) | 0.017 |
γGTP, IU/L | 21 (15–39) | 25 (18–46) | 0.007 |
BUN, mg/dL | 17 ± 7 | 17 ± 8 | 0.977 |
Creatinine, mg/dL | 0.72 (0.60–0.90) | 0.80 (0.64–1.00) | 0.114 |
eGFR, mL/min/1.73 m2 | 70 ± 25 | 67 ± 23 | 0.274 |
Uric acid, mg/dL | 4.8 ± 1.5 | 5.4 ± 1.3 | <0.001 |
TC, mg/dL | 190 ± 30 | 182 ± 36 | 0.050 |
LDL-C, mg/dL | 112 ± 23 | 105 ± 29 | 0.073 |
HDL-C, mg/dL | 63 ± 17 | 51 ± 14 | < 0.001 |
Non-HDL-C, mg/dL | 127 ± 26 | 130 ± 33 | 0.430 |
Triglycerides, mg/dL | 75 (52–100) | 109 (77–169) | <0.001 |
CRP, mg/dL | 0.07 (0.05–0.13) | 0.11 (0.06–0.20) | 0.009 |
Glucose, mg/dL | 173 (115–218) | 140 (118–171) | 0.047 |
Hemoglobin A1c, % | 7.4 (6.7–8.1) | 7.1 (6.5–7.9) | 0.097 |
C-peptide, ng/mL | 0.15 (0.15–0.71) | 1.69 (1.12–2.54) | <0.001 |
TNFR1, ng/mL | 1.33 (108–1.79) | 1.61 (1.28–2.18) | <0.001 |
TNFR2, ng/mL | 2.95 (2.38–4.04) | 3.43 (2.74–4.56) | 0.005 |
FABP4, ng/mL | 14.1 (9.0–17.3) | 17.6 (11.6–24.4) | 0.001 |
ALT, alanine transaminase; AST, aspartate transaminase; BMI, body mass index; BP, blood pressure; BUN, blood urea nitrogen; CRP, C-reactive protein; DM, diabetes mellitus; DPP-4, dipeptidyl peptidase-4; eGFR, estimated glomerular filtration rate; FABP4, fatty acid-binding protein 4; GLP-1, glucagon-like peptide-1; γGTP, γ-glutamyl transpeptidase; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; SGLT2, sodium-glucose co-transporter-2; TC, total cholesterol; TNFR, tumor necrosis factor receptor; T1DM, type 1 diabetes mellitus; T2DM, type 2 diabetes mellitus.